C07C 317/34
Having sulfone or sulfoxide groups and amino groups bound to carbon atoms
Official title: having sulfone or sulfoxide groups and amino groups bound to carbon atoms of six-membered aromatic rings being part of the same non-condensed ring or of a condensed ring system containing that ring
C07C317/34 (Having sulfone or sulfoxide groups and amino groups bound to carbon atoms) appears on 496 US grants and 433 published applications in this corpus.
Search patents in C07C- Granted patents
- 496
- Published applications
- 433
- Assignees
- 297
- Inventors
- 1,515
- Latest grant
- 30 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 3 | 0 |
| 1977 | 0 | 0 |
| 1978 | 4 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 3 | 0 |
| 1982 | 2 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 2 | 0 |
| 1986 | 0 | 0 |
| 1987 | 2 | 0 |
| 1988 | 2 | 0 |
| 1989 | 3 | 0 |
| 1990 | 7 | 0 |
| 1991 | 7 | 0 |
| 1992 | 11 | 0 |
| 1993 | 11 | 0 |
| 1994 | 14 | 0 |
| 1995 | 11 | 0 |
| 1996 | 14 | 0 |
| 1997 | 14 | 0 |
| 1998 | 11 | 0 |
| 1999 | 15 | 0 |
| 2000 | 8 | 0 |
| 2001 | 11 | 3 |
| 2002 | 21 | 22 |
| 2003 | 18 | 34 |
| 2004 | 28 | 33 |
| 2005 | 17 | 15 |
| 2006 | 12 | 21 |
| 2007 | 10 | 17 |
| 2008 | 6 | 11 |
| 2009 | 11 | 19 |
| 2010 | 15 | 17 |
| 2011 | 15 | 9 |
| 2012 | 10 | 9 |
| 2013 | 14 | 14 |
| 2014 | 14 | 21 |
| 2015 | 17 | 14 |
| 2016 | 11 | 17 |
| 2017 | 14 | 17 |
| 2018 | 18 | 27 |
| 2019 | 17 | 13 |
| 2020 | 10 | 17 |
| 2021 | 10 | 8 |
| 2022 | 12 | 17 |
| 2023 | 11 | 16 |
| 2024 | 14 | 21 |
| 2025 | 11 | 17 |
| 2026 | 5 | 4 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Substituted 3-amino-4-methylbenzenesulfonamides as small molecule inhibitors of ubiquitin-specific protease 2830 Jun 2026US 12,668,571 B2Dana-Farber Cancer Institute, Inc.
- USP30 inhibitors and uses thereof2 Jun 2026US 12,643,852 B2Vincere Biosciences, Inc.
- Antibacterial compounds2 Jun 2026US 12,643,875 B2The Penn State Research Foundation
- Compound as a UBR box domain ligand24 Feb 2026US 12,559,455 B2Autotac Inc.
- GPX4 inhibitors, pharmaceutical compositions thereof, and their use for treating GPX4-mediated diseases6 Jan 2026US 12,516,016 B2Eubulus Biotherapeutics (Hong Kong) Limited
- Usp30 inhibitors and uses thereof1 Oct 2026US 2026/0297026 A1Vincere Biosciences, Inc.
- Antibacterial compounds17 Sep 2026US 2026/0274816 A1The Penn State Research Foundation
- Chalcone-based chemotherapeutic compounds and treatments for cancer23 Jul 2026US 2026/0209209 A1Qatar University
- Dual inhibitors for hdac3 and hiv-1 pr15 Jan 2026US 2026/0014174 A1Purdue Research Foundation
- Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto27 Nov 2025US 2025/0359552 A1Corteva Agriscience LLC
Most cited
By later US patents
- Prostaglandin synthase inhibitors169US 5,593,994 AThe DuPont Merck Pharmaceutical Company · 1997
- Benzamides and related inhibitors of factor Xa155US 7,285,565 B2Millennium Pharmaceuticals, Inc. · 2007
- Tetraaryl benzidines128US 5,639,914 AHodogaya Chemical Co., Ltd. · 1997
- Amine compound and electro-luminescence device comprising same122US 5,707,747 AHodogaya Chemical Co., Ltd. · 1998
- Benzamides and related inhibitors of factor Xa115US 6,376,515 B2COR Therapeutics, Inc. · 2002